SUMMARY The excretion of sugar components of glycosaminoglycans in the urine was investigated in 19 healthy controls, 27 patients with rheumatoid arthritis, and 24 with osteoarthritis. Both groups of patients excreted significantly more glucosamine, galactosamine, and mannose than the controls. The total uronic acid excretion, also, was higher in the two groups than in the healthy subjects. The possibility of using this method for the long term follow up of rheumatoid arthritis and osteoarthritis and the response to treatment is discussed.
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Attempts to find a suitable method for qualitative and quantitative determination of connective tissue metabolites in blood and urine as an aid in diagnosis (e.g., cases of inborn errors of glycosaminoglycan metabolism) are not new. Clinical chemistry continues to seek more sensitive and more specific indicators of pathological processes affecting the articular connective tissue. Rheumatic diseases are characterised by cartilage degradation caused by enzymes produced either by the infiltrating cell, granulation tissue, or chondrocytes directly in the cartilage. l-3
Composition of the articular cartilage connective tissue is the result of a balance between the continual synthesis and degradation of proteoglycans, collagen, and other components. Degradation products of these molecules appear firstly in the blood and later in the urine.4 To obtain information on degradative processes affecting proteoglycans we analysed the sugar components of the glycosaminoglycans and small oligosaccharide chains appearing in the urine.
Patients and methods
Twenty four hour urine specimens were collected from 19 normal controls (10 women During the collection time (24 hours) urine was kept at 4°C in sterile containers without addition of preservatives. The urine volume (between 1000 and 1400 ml). pH, and specific gravity were recorded. An aliquot was assayed for creatinine and fragments with molecular weight of more than 4000 were isolated by permeation chromatography on Bio-Gel P4. The preparative gel filtration was performed using a modification of the technique of Hurst et al.4 After centrifugation a 25 ml sample of filtered urine was applied to a column of Pharmacia Fine Chemicals (K 26/40) packed with Bio-Gel P4 (100-200 gm mesh) to a bed volume of 159-3 ml. The sample was eluted with deionised water. The first 65 ml of eluate was discarded and the next 80 ml retained as the macromolecular fraction. The column was then washed with five bed volumes of water. After every fifth sample the column was regenerated by a solution of 2 M urea in 1 M NaCl followed by 10 
Results
Significant differences between the groups of patients and the control group were observed, mainly in the glucosamine and galactosamine content (Table 1) . Both of these amino sugars were present in higher levels in the urine of patients with rheumatoid arthritis and osteoarthritis. There was also some difference in the mannose content. Table  1 shows the mean values, standard deviations, and significance levels of differences between the controls and groups of patients. The group of osteoarthritic patients was not homogeneous. For this reason it was divided into two subgroups according to x ray findings: (a) mild (stages I and I1) and (b) advanced (stages III and IV). The differences between these subgroups were not substantial, significant differences occurring mainly in the fucose and xylose content belonging to the oligosaccharide chains ( Table 2 ). In rheumatoid patients no relation could be found between stage of the disease (Steinbrocker), disease activity, and the level of excretion of proteoglycan degradation products.
Excretion of uronic acids in healthy subjects was lower than in the patients: the average content of uronic acids in 24 hour urine was 5-0 mg in the control group, 7*9 mg in the group of patients with rheumatoid arthritis, and 6 1 mg in the group with osteoarthritis.
Discussion
The extracellular matrix of connective tissue consists to a large extent of glycosaminoglycans in the form of proteoglycans, which are covalently bound to a central core protein. Recently, two further components of proteoglycans have been described. Of these small oligosaccharide chains," 2 one type is bound to the core protein by an O-glycoside bond containing galactosamine, galactose, glucosamine, and sialic acid. The second type has a higher molecular weight, contains mainly mannose and also glucosamine, galactose, sialic acid, and fucose, and is bound by an N-glycoside bond to the core protein, almost exclusively in its terminal globular part, which contains the hyaluronic acid binding region.
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